Release Date: 17/02/23 19:00 Summary: Change of Director's Interest Notice x 2 Price Sensitive: No Download Document 252.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%